Overview
Immunochem offers AI-constructed VHHs and minibinders that are wet-lab validated, working from any antigen including toxic or non-immunogenic ones. The company targets Scientific Managers in Bio-Pharmaceutical companies seeking to streamline antibody generation processes and improve reproducibility.
Key people
In the news
Something wrong or missing? Send an update. Fixed within 24 hours.